Patient-derived glioblastoma stem cells respond differentially to targeted therapiesPratik Kanabur, Zhi Sheng|Oncotarget|2016Cited by 41
Long‐term outcomes of bladder‐sparing therapy vs radical cystectomy in BCG‐unresponsive non‐muscle‐invasive bladder cancerJacob Taylor, Yair Lotan, Jayanthi Raman et al.|British Journal of Urology|2024Cited by 27
Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin–Unresponsive Non–Muscle Invasive Bladder CancerJacob Taylor, Michael A. O’Donnell, Ashish M. Kamat et al.|European Urology Oncology|2024Cited by 19
Impact of Tumor Stage on Oncologic Outcomes of High-grade Bacillus Calmette-Guérin Unresponsive Non–muscle-invasive Bladder Cancer Undergoing Bladder-sparing TherapiesDrupad Annapureddy, Yair Lotan, Jacob Taylor et al.|European Urology Focus|2025Cited by 2
NATURAL HISTORY OF BLADDER-SPARING THERAPY IN PATIENTS WITH BCG-UNRESPONSIVE DISEASE; RESULTS FROM A LARGE MULTI-CENTER COHORTJacob Taylor, William C. Huang, Drupad Annapureddy et al.|Urologic Oncology Seminars and Original Investigations|2024Cited by 1